• Disease Overview
  • Subdivisions
  • Signs & Symptoms
  • Causes
  • Affected Populations
  • Disorders with Similar Symptoms
  • Diagnosis
  • Standard Therapies
  • Clinical Trials and Studies
  • References
  • Programs & Resources
  • Complete Report
Select language / seleccionar idioma:

GJB2-Related Conditions

Print

Last updated: 6/12/2025
Years published: 2025


Acknowledgment

NORD gratefully acknowledges Jessica Aderman, DO, and Christina Sloan-Heggen, MD, PhD, University of Michigan, for the preparation of this report.


Disease Overview

Summary

GJB2-related conditions are a group of genetic disorders primarily associated with hearing loss and/or deafness that result from changes (variants) in the GJB2 gene. Variants in the GJB2 gene are among the most common causes of hearing loss globally. While hearing loss is the main symptom in GJB2-related conditions, some conditions related to GJB2 variants can be multi-symptom disorders (syndromes) involving skin and hair abnormalities. Most people with GJB2-related conditions have hearing loss at birth, but the severity and age of onset can vary. The treatment for GJB2-related conditions focuses on managing symptoms since there is currently no cure. Early diagnosis can enhance the quality of life using hearing aids or cochlear implants. For syndromic forms of GJB2-related disorders, such as those affecting the skin, additional treatments may be necessary to manage these symptoms.1-3

There are several conditions that can be caused by GJB2 variants including:

  • GJB2-related autosomal recessive nonsyndromic hearing loss (GJB2-AR NSHL) is the leading genetic cause for severe-to-profound sensorineural hearing loss present at birth across many populations worldwide. It is also known as autosomal recessive deafness-1A (DFNB1A).1
  • GJB2-related autosomal dominant hearing loss (GJB2-AD NSHL) is a much rarer cause of sensorineural hearing loss and typically associated with other findings (syndromic). When only associated with hearing loss (isolated or nonsyndromic) this can also be referred to as autosomal dominant deafness-3A (DFNA3A).4
  • Several syndromes include hearing loss and other problems.1,2 These include:
    • Keratitis-ichthyosis-deafness syndrome (KID) is present at birth and associated with eye conditions including light sensitivity and sores (ulceration) of the cornea and scarring. Skin changes include thickened plaques and thickened skin on the hands and feet (hyperkeratosis). Sensorineural hearing loss and sparse hair with nail differences can also be seen.2,5
    • Hystrix-like ichthyosis with deafness (HID) typically present in the first year of life with skin conditions including dry, scaly skin (ichthyosis) and red, scaly, inflamed skin on most or all of the body (erythroderma). Sometimes thinning hair and patches of balding are seen. Eye conditions can be found with HID including formation of small, pinpoint defects on the corneal surface (punctate keratitis). It is associated with sensorineural hearing loss.6
    • Palmoplantar keratoderma (PPK) with deafness-typically starts in childhood with skin thickening (keratoderma) of the palms and soles along with varying degrees of sensorineural hearing loss.7
    • Vohwinkel syndrome (VOWNKL) includes raised (papular) and honeycomb-like thickening of the skin (keratoderma). Affected people can have tightened areas (constrictions) in the fingers and toes that can result in loss of the fingers or toes (autoamputation). Additionally, there are unique starfish-shaped keratoses on the extremities and sensorineural hearing loss is typically moderate.8
    • Bart-Pumphrey syndrome (BAPS) presents with palmoplantar keratoderma, white spots on the nails (leukonychia), painless nodules at the knuckles (knuckle pads), and sensorineural hearing loss.9

Introduction

GJB2 nonsyndromic hearing loss was among the first genetic causes of hearing loss to have its location in the genome found and then the gene identified in 1997. This was important in providing a genetic reason for a large group of people with hearing loss. Many studies have shown GJB2 variants as a frequent cause of nonsyndromic hearing loss.10,11 PPK was identified that same year and further research published in the next few years provided a better understanding of variation in GJB2-related conditions.12-14 Continued research led to the association of VOWNKL syndrome (1999) and KID syndrome (2002). These discoveries continued to highlight the role of GJB2 in both hearing and skin-related functions.15-17 Given similarities between KID and HID, HID was quickly found to be associated with GJB2 variants as well. It was noticed that, on a molecular level, KID and HID look the same.18 BAPS was most recently associated with GJB2 variants. This finding continued to expand our understanding of associated conditions.19

  • Next section >
  • < Previous section
  • Next section >

Subdivisions

GJB2-related autosomal recessive nonsyndromic hearing loss (GJB2-AR NSHL) also known as:

  • autosomal recessive deafness-1A (DFNB1A)
  • autosomal recessive nonsyndromic deafness 1A
  • autosomal recessive nonsyndromic deafness type 1A
  • autosomal recessive nonsyndromic hearing loss 1A
  • deafness, autosomal recessive 1A
  • deafness, autosomal recessive type 1A
  • GJB2-related deafness
  • connexin 26 deafness
  • deafness nonsyndromic, connexin 26 linked
  • DFNB1

GJB2-related autosomal dominant nonsyndromic hearing loss (GJB2-AD NSHL) also known as:

  • autosomal dominant deafness-3A (DFNA3A)
  • autosomal dominant nonsyndromic deafness 3A
  • autosomal dominant nonsyndromic deafness type 3A
  • deafness, autosomal dominant 3A
  • deafness, autosomal dominant 3a
  • deafness, autosomal dominant nonsyndromic sensorineural 3
  • deafness, autosomal dominant type 3A
  • neurosensory nonsyndromic dominant deafness 1
  • autosomal dominant nonsyndromic deafness caused by mutation in GJB2
  • GJB2 autosomal dominant nonsyndromic deafness
  • DFNA3

keratitis-ichthyosis-deafness syndrome (KID) also known as:

  • KID syndrome
  • autosomal dominant keratitis-ichthyosis-deafness syndrome (KIDAD)
  • ichthyosiform erythroderma, corneal involvement, and deafness syndrome

hystrix-like ichthyosis with deafness (HID) also known as:

  • HID syndrome
  • ichthyosis, hystrix-like, with deafness

palmoplantar keratoderma (PPK) with deafness also known as:

  • keratoderma palmoplantar deafness
  • keratoderma palmoplantar, with deafness
  • keratoderma, palmoplantar, with deafness
  • palmoplantar keratoderma and sensorineural deafness
  • palmoplantar keratoderma-hearing loss syndrome
  • palmoplantar hyperkeratosis-deafness syndrome
  • palmoplantar hyperkeratosis-hearing loss syndrome
  • PPK-deafness syndrome
  • PPK with deafness
  • diffuse palmoplantar keratoderma with deafness
  • focal palmoplantar keratoderma with sensorineural deafness
  • hereditary palmoplantar keratoderma with deafness

Vohwinkel syndrome (VOWNKL) also referred to as:

  • keratoderma hereditarium mutilans (KHM)
  • mutilating keratoderma of Vohwinkel
  • mutilating keratoderma plus deafness
  • mutilating keratoderma
  • PPK mutilans and deafness
  • deafness, congenital, with keratopachydermia and constrictions of fingers and toes

Bart-Pumphrey syndrome (BAPS) also referred to as:

  • knuckle pads-leukonychia-sensorineural deafness-palmoplantar keratoderma syndrome
  • knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome
  • knuckle pads, leukonychia, and sensorineural deafness
  • knuckle pads, leuconychia and sensorineural deafness
  • < Previous section
  • Next section >
  • < Previous section
  • Next section >

Signs & Symptoms

Variants of the GJB2 gene can lead to a variety of symptoms associated with the following conditions:

GJB2-related autosomal recessive nonsyndromic hearing loss (GJB2-AR NSHL)

GJB2-AR NSHL is sensorineural, meaning it results from problems in the inner ear involving the cochlea or auditory nerves. GJB2-AR NSHL is typically severe to profound and usually present at birth (congenital). It is usually stable and not progressive. If an individual has mild to moderate hearing loss it may progress over time. The only symptom is hearing loss, with no other associated symptoms.1

GJB2-related autosomal dominant nonsyndromic hearing loss (GJB2-AD NSHL)

GJB2-AD NSHL is sensorineural hearing loss caused by variants in the GJB2 gene and can vary significantly in terms of age of onset. It can present in infancy but often presents in adolescence or adulthood and can depend on the specific variant. The only symptom is hearing loss, with no other associated symptoms.1,4,20

Keratitis-ichthyosis-deafness syndrome (KID)

Individuals with KID can have serious vision problems due to issues with blood vessels in the eyes, significant hearing loss and worsening skin thickening and redness. This happens because certain layers of skin and other tissues do not develop properly1.17 Some symptoms start at birth and others develop with time.21 Common symptoms include:

  • Sensorineural hearing loss
  • Blindness
  • Decreased tear production (keratoconjunctivitis sicca)
  • Limited hair
  • Eyelid and eyelash problems such as:
    • Thickened eyelashes making it difficult to move the eyelids
    • Eyelashes that grow inward toward the eye (trichiasis) which can damage the eye
  • Elbow or knee contractures
  • Tight heel cords
  • High arched feet (pes cavus)
  • Fissured tongue
  • White patches that form on certain areas of the mouth, such as the tongue, gums and inner cheeks (oral leukoplakia)
  • Nail differences
  • Skin differences such as:
    • Extensive redness and scaling of the skin (erythroderma)
    • Red patches that can change shape and location (erythrokeratoderma)
    • Persistent, thickened, scaly areas (hyperkeratotic plaques)
    • Skin that does not shed properly (lamellar ichthyosis)
    • Decreased sweating
    • Recurrent skin infections
  • Increased risk of squamous cell carcinoma of the skin and tongue5,16,17

Hystrix-Like ichthyosis with deafness (HID) syndrome

HID syndrome presents with both sensorineural hearing loss and skin differences.

Common symptoms include:

  • Sensorineural hearing loss
  • No hair or limited hair
  • High arched feet (pes cavus)
  • Skin differences including erythroderma, spiky thickening of the skin (spiky hyperkeratosis), and ichthyosis
  • Eye conditions including punctate keratitis
  • Squamous cell carcinoma6,18

Palmoplantar keratoderma with deafness

Palmoplantar keratoderma with deafness is a condition where thickened skin appears on the palms and soles (palmoplantar hyperkeratosis), accompanied by varying degrees of sensorineural hearing loss that progresses over time. Symptoms begin in childhood, and there are no other skin or systemic issues noted.7,14,22

Vohwinkel syndrome (VOWNKL)

Classic Vohwinkel syndrome has a unique thickened pattern to the skin that is often described as honeycomb or starfish-like (honeycomb keratoderma or starfish-like keratoses). Constrictive bands can form on the fingers and toes (pseudoainhum) that can lead to loss of part or all of the fingers/toes involved (autoamputation). VOWNKL includes mild to moderate sensorineural hearing loss.8,15

Bart-Pumphrey syndrome (BAPS)

People with BAPS have symptoms that affect the hearing, skin and nails. The presentation of these characteristics can vary significantly among individuals.

Common symptoms include:

  • Knuckle pads
  • Leukonychia
  • Sensorineural hearing loss
  • Palmoplantar keratosis9,19

The severity of symptoms linked to GJB2-related conditions can differ significantly among individuals. Each person might experience a different set of symptoms.

  • < Previous section
  • Next section >
  • < Previous section
  • Next section >

Causes

GJB2-related disorders are caused by changes (variants) in the GJB2 gene, which provides instructions for making a protein called connexin 26. This protein is a component of gap junctions, which are channels that allow the passage of ions and small molecules between cells. These channels are important for cell communication, especially in the inner ear as well as the skin and cornea. Variants in the GJB2 gene can lead to impaired production or function of connexin 26, disrupting cell communication and resulting in hearing loss and sometimes skin disorders and corneal defects.2,19

Inheritance

GJB2-related conditions are inherited in two ways, depending on the specific disorder.

GJB2-AR NSHL is inherited in an autosomal recessive pattern. Recessive genetic disorders occur when an individual inherits a disease-causing gene variant from each parent. If an individual receives one normal gene and one disease-causing gene variant, the person will be a carrier for the disease but usually will not show symptoms. The risk for two carrier parents to both pass the gene variant and have an affected child is 25% with each pregnancy. The risk of having a child who is a carrier like the parents is 50% with each pregnancy. The chance for a child to receive normal genes from both parents is 25%. The risk is the same for males and females.

GJB2-AD NSHL, KID, HID, palmoplantar keratoderma with deafness, Vohwinkel syndrome, and BAPS are inherited in an autosomal dominant pattern. Dominant genetic disorders occur when only a single copy of a disease-causing gene variant is necessary to cause the disease. The gene variant can be inherited from either an affected parent or can be the result of a newly (de novo) changed gene in the affected individual that is not inherited. The risk of passing the gene variant from an affected parent to a child is 50% for each pregnancy. The risk is the same for males and females.

In some individuals, a GJB2 variant can appear spontaneously, known as a de novo variant, meaning it is not passed down from either parent.1,2 Such variants arise during the creation of reproductive cells (eggs and sperm) or at the early stages of embryonic development, resulting in the genetic change being present in the child without prior occurrence in the family.

  • < Previous section
  • Next section >
  • < Previous section
  • Next section >

Affected populations

Variants in GJB2 are a well-known cause of nonsyndromic sensorineural hereditary hearing loss, particularly autosomal recessive forms. GJB2 variants are one of the most common genetic causes of congenital deafness worldwide.1

Hearing impairment (HI) occurs in about 1 in 650 newborns.24 Some of these are caused by genetic variants, while others are not. Approximately 80% of hearing loss caused by genetic variants have an autosomal recessive inheritance pattern. Of these, around 30% of the cases are linked to syndromes. The remaining 70% are classified as nonsyndromic hearing loss. Of these remaining cases, GJB2 variants account for up to 50% of autosomal recessive nonsyndromic hearing loss cases globally, making it the gene most frequently associated with this form of hearing loss.25,26

The prevalence of GJB2-AR NSHL varies significantly among different populations. It is more common among certain ethnic groups, such as Ashkenazi Jews and some Asian and European populations.1,20 For example, research has shown that the c.35delG variant in GJB2 is a prevalent cause of hereditary hearing loss in European populations.27 Other variants appear more common in different populations, such as the 235delC variant observed more often in East Asian populations.26,28

GJB2-related conditions can affect both males and females and have been observed in individuals from diverse ethnic groups. GJB2-AR NSHL is relatively common, but other GJB2-related conditions are considered rare. It is not known exactly how rare they are, but not many cases have been recorded in medical literature.1,2,29 However, as awareness about these conditions grows, more people may be recognized, providing a better understanding of its actual occurrence in the general population.

  • < Previous section
  • Next section >
  • < Previous section
  • Next section >

Diagnosis

Diagnosing GJB2-related conditions involves a combination of clinical assessment and genetic testing. The first step involves collecting history and a physical examination to identify symptoms consistent with GJB2 variants. Findings discussed above may lead a doctor to suspect GJB2-related conditions. Gathering a detailed family history may suggest an inheritance pattern. For those with hearing loss, hearing (audiological) evaluations will measure the degree and type of hearing impairment. In people with skin symptoms, a skin biopsy may be taken to determine the skin disease present.1,2,12,19,29

The definitive diagnosis as a GJB2-related condition is made through genetic testing, which involves analyzing the GJB2 gene for variants.1

  • < Previous section
  • Next section >
  • < Previous section
  • Next section >

Standard Therapies

As of now, there is no cure for genetic conditions caused by variants in the GJB2 gene. However, there are management and treatment options available to help manage symptoms and improve quality of life. These options include:

  • Hearing aids can amplify sound and help people with hearing loss to hear more clearly.
  • Cochlear implants: For individuals with severe or profound hearing loss, cochlear implants can provide a sense of sound by directly stimulating the auditory nerve.
  • Speech therapy can help improve communication skills.
  • Noise protection: Individuals who have confirmed hearing loss should receive proper counseling to refrain from repeated exposure to loud noises, which could worsen their hearing.1,20

Skin conditions should be addressed by a dermatologist and treatment depends on condition present.3

People with eye conditions should have regular visits with an ophthalmologist to address the concerns.36

Tailored educational plans and resources can assist people with hearing loss/vision loss in their learning and day-to-day activities.

Genetic counseling for individuals and their families is recommended to provide information about the genetic aspects of hearing loss.1,20

  • < Previous section
  • Next section >
  • < Previous section
  • Next section >

Clinical Trials and Studies

Information on current clinical trials is posted on the Internet at https://clinicaltrials.gov/ All studies receiving U.S. Government funding, and some supported by private industry, are posted on this government web site.

For more information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:

Tollfree: (800) 411-1222
TTY: (866) 411-1010
Email: [email protected]

Some current clinical trials also are posted on the following page on the NORD website: https://rarediseases.org/living-with-a-rare-disease/find-clinical-trials/

For information about clinical trials sponsored by private sources, contact: http://www.centerwatch.com/

For information about clinical trials conducted in Europe, contact:https://www.clinicaltrialsregister.eu/

  • < Previous section
  • Next section >
  • < Previous section
  • Next section >

References

  1. Smith RJH, Azaiez H, Booth K. GJB2-Related Autosomal Recessive Nonsyndromic Hearing Loss. 1998 Sep 28 [Updated 2023 Jul 20]. In: Adam MP, Feldman J, Mirzaa GM, et al., eds. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2025. https://www.ncbi.nlm.nih.gov/books/NBK1272/ Accessed May 20, 2025.
  2. Online Mendelian Inheritance in Man (OMIM). Updated December 11, 2024. Accessed March 26, 2025. https://www.omim.org/entry/121011 Accessed May 20, 2025.
  3. Bondeson ML, Nyström AM, Gunnarsson U, Vahlquist A. Connexin 26 (GJB2) mutations in two Swedish patients with atypical Vohwinkel (mutilating keratoderma plus deafness) and KID syndrome both extensively treated with acitretin. Acta Derm Venereol. 2006;86(6):503-508. doi:10.2340/00015555-0164
  4. Online Mendelian Inheritance in Man (OMIM). Updated January 16, 2020. Accessed March 26, 2025. https://www.omim.org/entry/601544.
  5. Online Mendelian Inheritance in Man (OMIM). Updated January 4, 2024. https://www.omim.org/entry/148210 Accessed May 20, 2025.
  6. Online Mendelian Inheritance in Man (OMIM). Updated September 30, 2024. https://www.omim.org/entry/602540 Accessed May 20, 2025.
  7. Online Mendelian Inheritance in Man (OMIM). Updated January 27, 2025. https://www.omim.org/entry/148350 Accessed May 20, 2025.
  8. Online Mendelian Inheritance in Man (OMIM). Updated August 22, 2023. https://www.omim.org/entry/124500 Accessed May 20, 2025.
  9. Online Mendelian Inheritance in Man (OMIM). Updated August 9, 2022. https://www.omim.org/entry/149200 Accessed May 20, 2025.
  10. Kelsell DP, Dunlop J, Stevens HP, et al. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature. 1997;387(6628):80-83. doi:10.1038/387080a0
  11. Denoyelle F, Weil D, Maw MA, et al. Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene. Hum Mol Genet. 1997;6(12):2173-2177. doi:10.1093/hmg/6.12.2173
  12. Richard G, White TW, Smith LE, et al. Functional defects of Cx26 resulting from a heterozygous missense mutation in a family with dominant deaf-mutism and palmoplantar keratoderma. Hum Genet. 1998;103(4):393-399. doi:10.1007/s004390050839
  13. Heathcote K, Syrris P, Carter ND, Patton MA. A connexin 26 mutation causes a syndrome of sensorineural hearing loss and palmoplantar hyperkeratosis (MIM 148350). J Med Genet. 2000;37(1):50-51. doi:10.1136/jmg.37.1.50
  14. Uyguner O, Tukel T, Baykal C, et al. The novel R75Q mutation in the GJB2 gene causes autosomal dominant hearing loss and palmoplantar keratoderma in a Turkish family. Clin Genet. 2002;62(4):306-309. doi:10.1034/j.1399-0004.2002.620409.x
  15. Maestrini E, Korge BP, Ocaña-Sierra J, et al. A missense mutation in connexin26, D66H, causes mutilating keratoderma with sensorineural deafness (Vohwinkel’s syndrome) in three unrelated families. Hum Mol Genet. 1999;8(7):1237-1243. doi:10.1093/hmg/8.7.1237
  16. van Steensel MA, van Geel M, Nahuys M, Smitt JH, Steijlen PM. A novel connexin 26 mutation in a patient diagnosed with keratitis-ichthyosis-deafness syndrome. J Invest Dermatol. 2002;118(4):724-727. doi:10.1046/j.1523-1747.2002.01735.x
  17. Richard G, Rouan F, Willoughby CE, et al. Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome. Am J Hum Genet. 2002;70(5):1341-1348. doi:10.1086/339986
  18. van Geel M, van Steensel MA, Küster W, et al. HID and KID syndromes are associated with the same connexin 26 mutation. Br J Dermatol. 2002;146(6):938-942. doi:10.1046/j.1365-2133.2002.04893.x
  19. Richard G, Brown N, Ishida-Yamamoto A, Krol A. Expanding the phenotypic spectrum of Cx26 disorders: Bart-Pumphrey syndrome is caused by a novel missense mutation in GJB2. J Invest Dermatol. 2004;123(5):856-863. doi:10.1111/j.0022-202X.2004.23470.x
  20. Shearer AE, Hildebrand MS, Odell AM, et al. Genetic Hearing Loss Overview. 1999 Feb 14 [Updated 2023 Sep 28]. In: Adam MP, Feldman J, Mirzaa GM, et al., eds. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2025. https://www.ncbi.nlm.nih.gov/books/NBK1434/ Accessed May 20, 2025.
  21. Richard G. Autosomal Recessive Congenital Ichthyosis. 2001 Jan 10 [Updated 2023 Apr 20]. In: Adam MP, Feldman J, Mirzaa GM, et al., eds. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2025. https://www.ncbi.nlm.nih.gov/books/NBK1420/ Accessed May 20, 2025.
  22. de Zwart-Storm EA, Hamm H, Stoevesandt J, et al. A novel missense mutation in GJB2 disturbs gap junction protein transport and causes focal palmoplantar keratoderma with deafness. J Med Genet. 2008;45(3):161-166. doi:10.1136/jmg.2007.052332
  23. Online Mendelian Inheritance in Man (OMIM). Updated September 9, 2024. https://www.omim.org/entry/220290 Accessed May 20, 2025.
  24. Mehl AL, Thomson V. The Colorado newborn hearing screening project, 1992-1999: on the threshold of effective population-based universal newborn hearing screening. Pediatrics. 2002;109(1):E7. doi:10.1542/peds.109.1.e7
  25. Morton NE. Genetic epidemiology of hearing impairment. Ann N Y Acad Sci. 1991;630:16-31. doi:10.1111/j.1749-6632.1991.tb19572.x
  26. Snoeckx RL, Huygen PL, Feldmann D, et al. GJB2 mutations and degree of hearing loss: a multicenter study. Am J Hum Genet. 2005;77(6):945-957. doi:10.1086/497996
  27. Gasparini P, Rabionet R, Barbujani G, et al. High carrier frequency of the 35delG deafness mutation in European populations. Genetic Analysis Consortium of GJB2 35delG. Eur J Hum Genet. 2000;8(1):19-23. doi:10.1038/sj.ejhg.5200406
  28. Zhang J, Wang H, Yan C, et al. The Frequency of Common Deafness-Associated Variants Among 3,555,336 Newborns in China and 141,456 Individuals Across Seven Populations Worldwide. Ear Hear. 2023;44(1):232-241. doi:10.1097/AUD.0000000000001274
  29. Iossa S, Marciano E, Franzé A. GJB2 Gene Mutations in Syndromic Skin Diseases with Sensorineural Hearing Loss. Curr Genomics. 2011;12(7):475-785. doi:10.2174/138920211797904098
  30. Walls WD, Azaiez H, Smith RJH. Hereditary Hearing Loss Homepage. Updated February 19, 2025. https://hereditaryhearingloss.org/ Accessed May 20, 2025.
  31. Mellerio J, Greenblatt D. Hidrotic Ectodermal Dysplasia 2. 2005 Apr 25 [Updated 2020 Oct 15]. In: Adam MP, Feldman J, Mirzaa GM, et al., eds. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2025. https://www.ncbi.nlm.nih.gov/books/NBK1200/ Accessed May 20, 2025.
  32. Online Mendelian Inheritance in Man (OMIM). Updated June 4, 2022. https://www.omim.org/entry/590080. Accessed May 20, 2025.
  33. Online Mendelian Inheritance in Man (OMIM). Updated February 19, 2020. https://www.omim.org/entry/604117 Accessed May 20, 2025.
  34. Online Mendelian Inheritance in Man (OMIM). Updated August 17, 2023. https://www.omim.org/entry/614594 Accessed May 20, 2025.
  35. Online Mendelian Inheritance in Man (OMIM). Updated May 15, 2024. https://www.omim.org/entry/167200 Accessed May 20, 2025.
  36. Kalezić T, Vuković I, Stojković M, et al. Keratitis-ichthyosis-deafness Syndrome with Heterozygous p.D50N in the GJB2 Gene in Two Serbian Adult Patients. Balkan J Med Genet. 2023;25(1):79-84. Published 2023 Mar 1. doi:10.2478/bjmg-2022-0014
  • < Previous section
  • Next section >

Programs & Resources

RareCare logo in two lines.

RareCare® Assistance Programs

NORD strives to open new assistance programs as funding allows. If we don’t have a program for you now, please continue to check back with us.

Additional Assistance Programs

MedicAlert Assistance Program

NORD and MedicAlert Foundation have teamed up on a new program to provide protection to rare disease patients in emergency situations.

Learn more https://rarediseases.org/patient-assistance-programs/medicalert-assistance-program/

Rare Disease Educational Support Program

Ensuring that patients and caregivers are armed with the tools they need to live their best lives while managing their rare condition is a vital part of NORD’s mission.

Learn more https://rarediseases.org/patient-assistance-programs/rare-disease-educational-support/

Rare Caregiver Respite Program

This first-of-its-kind assistance program is designed for caregivers of a child or adult diagnosed with a rare disorder.

Learn more https://rarediseases.org/patient-assistance-programs/caregiver-respite/

Patient Organizations


Access State Report Card Data

Please complete this form to access the requested resource.

Please consider sharing some basic information with us.

Name(Required)
This field is hidden when viewing the form